Related references
Note: Only part of the references are listed.Systematic Identification of Thiosemicarbazides for Inhibition of Toxoplasma gondii Growth In Vitro
Agata Paneth et al.
MOLECULES (2019)
Current treatment of ocular toxoplasmosis in immunocompetent patients: a network meta-analysis
Yanxia Zhang et al.
ACTA TROPICA (2018)
Lipophilic Permeability Efficiency Reconciles the Opposing Roles of Lipophilicity in Membrane Permeability and Aqueous Solubility
Matthew R. Naylor et al.
JOURNAL OF MEDICINAL CHEMISTRY (2018)
A systematic review and meta-analysis of the relative efficacy and safety of treatment regimens for HIV-associated cerebral toxoplasmosis: is trimethoprim-sulfamethoxazole a real option?
A. V. Hernandez et al.
HIV MEDICINE (2017)
Novel Molecules To Treat Chronic Central Nervous System Toxoplasmosis
Sandhya Kortagere
JOURNAL OF MEDICINAL CHEMISTRY (2017)
Predicting a Drug's Membrane Permeability: A Computational Model Validated With in Vitro Permeability Assay Data
Brian J. Bennion et al.
JOURNAL OF PHYSICAL CHEMISTRY B (2017)
Adverse Event Profile of Pyrimethamine-Based Therapy in Toxoplasmosis: A Systematic Review
Ruben R. Ben-Harari et al.
DRUGS IN R&D (2017)
A Systematic Review and Meta-Analysis of the Efficacy of Anti-Toxoplasma gondii Medicines in Humans
Hai-Xia Wei et al.
PLOS ONE (2015)
Congenital parasitic infections: A review
Yves Carlier et al.
ACTA TROPICA (2012)
Mechanisms of Toxoplasma gondii persistence and latency
William J. Sullivan et al.
FEMS MICROBIOLOGY REVIEWS (2012)
Synthesis and antimicrobial activity of thiosemicarbazides, s-triazoles and their Mannich bases bearing 3-chlorophenyl moiety
Tomasz Plech et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2011)
Synthesis and evaluation of anti-Toxoplasma gondii and antimicrobial activities of thiosemicarbazides, 4-thiazolidinones and 1,3,4-thiadiazoles
Andre P. Liesen et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2010)
Study of Direction of Cyclization of 1-Azolil-4-Aryl/Alkyl-Thiosemicarbazides
Agata Siwek et al.
HETEROATOM CHEMISTRY (2010)
Discovery of Inducible Nitric Oxide Synthase (iNOS) Inhibitor Development Candidate KD7332, Part 1: Identification of a Novel, Potent, and Selective Series of Quinolinone iNOS Dimerization Inhibitors that are Orally Active in Rodent Pain Models
Celine Bonnefous et al.
JOURNAL OF MEDICINAL CHEMISTRY (2009)
A new generation of specific Tryponosoma cruzi trans-sialidase inhibitors
Sabrina Buchini et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2008)
Toxoplasma gondii infection in humans and animals in the United States
J. P. Dubey et al.
INTERNATIONAL JOURNAL FOR PARASITOLOGY (2008)
Synthesis, cruzain docking, and in vitro studies of aryl-4-oxothiazolylhydrazones against Trypanosoma cruzi
Ana Cristina Lima Leite et al.
CHEMMEDCHEM (2007)
Halogenation of drugs enhances membrane binding and permeation
G Gerebtzoff et al.
CHEMBIOCHEM (2004)
Toxoplasma gondii:: from animals to humans
AM Tenter et al.
INTERNATIONAL JOURNAL FOR PARASITOLOGY (2000)
Share Paper
